BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33070930
Number of visits today
4152
Number of downloads
16272532
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Kobayashi T, Takeuchi A, Nishiyama H, Eto M. Current status and future perspectives of immunotherapy against urothelial and kidney cancer. Jpn J Clin Oncol 2021:hyab121. [PMID: 34389866 DOI: 10.1093/jjco/hyab121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kunitoh H. Message from the Editor-in-Chief. Jpn J Clin Oncol 2023;53:1-3. [PMID: 36611291 DOI: 10.1093/jjco/hyac196] [Reference Citation Analysis]
2 Feng H, Kou X, Tang Z, Li L, V E S. FYU-Net: A Cascading Segmentation Network for Kidney Tumor Medical Imaging. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/4792532] [Reference Citation Analysis]
3 Sakatani T, Kita Y, Fujimoto M, Sano T, Hamada A, Nakamura K, Takada H, Goto T, Sawada A, Akamatsu S, Kobayashi T. IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab. Cancers (Basel) 2022;14:263. [PMID: 35053427 DOI: 10.3390/cancers14020263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Kunitoh H. Message from the Editor-in-Chief. Jpn J Clin Oncol 2022;52:1-2. [PMID: 34978327 DOI: 10.1093/jjco/hyab190] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345